FIELD: medicine.
SUBSTANCE: method involves introducing steroid preparations of prolonged action into hemangioma region. Cyclophosphamide is additionally introduced at a dose of 3-5 mg/kg of child body mass into the same region. The preparations are introduced in 2-4 points once per 3-4 weeks with 3-5 procedures per course.
EFFECT: accelerated hemangioma regress; improved cosmetic efficiency.
2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING HEMANGIOMAS OF COMPLICATED ANATOMICAL LOCALISATION | 2011 |
|
RU2465026C1 |
| METHOD OF TREATING COMBINED AND CAVERNOUS HEMANGIOMAS | 2012 |
|
RU2517573C2 |
| METHOD AND PREPARATION FOR TREATING AUTOIMMUNE THYROIDITIS | 2005 |
|
RU2297226C1 |
| DRUG-INDUCED LIPOATROPHY FOR COSMETIC PURPOSES | 2010 |
|
RU2530629C2 |
| COMPOSITION OF THE OINTMENT AND THE METHOD OF TREATMENT OF SUPERFICIALLY LOCATED FORMS OF INFANTILE SKIN HEMANGIOMAS IN CHILDREN WITH ITS HELP | 2022 |
|
RU2800945C1 |
| METHOD FOR TREATING HEMANGIOMAE | 1992 |
|
RU2076644C1 |
| METHOD FOR MAXILLOFACIAL REGION INFANTILE HEMANGIOMA TREATMENT FOR CHILDREN | 2015 |
|
RU2615284C2 |
| METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED CANCER OF NASAL CAVITY AND PARANASAL SINUSES | 2020 |
|
RU2748636C1 |
| METHOD FOR PREVENTING RADIAL PALPEBRAL LESIONS AT PROTONOTHERAPY OF MALIGNANT ORBITAL TUMORS | 2005 |
|
RU2284802C1 |
| METHOD FOR PREDICTING HEMANGIOMA TREATMENT EFFICIENCY | 2004 |
|
RU2268469C2 |
